"These data add to the increasing body of evidence supporting use of REGEN-COV to prevent COVID-19 in uninfected individuals," said Regeneron's chief scientific officer George Yancopolous.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback